julie kim takeda - Search News

Julie Kim Will Succeed Christophe Weber

Takeda Pharmaceutical Names U.S. Head Julie Kim as Next CEO

The Japanese drugmaker said that Kim, president of its U.S. business unit, will succeed Chief Executive Christophe Weber, who plans to retire in June next year.

YAHOO!Finance · 3d

Julie Kim Will Succeed Christophe Weber as CEO of Takeda in June 2026

Takeda (TOKYO:4502/NYSE:TAK) announced today that its Board of Directors made the decision unanimously to appoint Julie Kim, currently president of Takeda’s U.S. Business Unit, as the successor to Christophe Weber,

Hosted on MSN · 2d

Takeda announces appointment of Julie Kim as CEO

I am excited to guide Takeda through the next phase, together with our exceptional and talented people, while staying true to our strong culture that is rooted in our

ジャパンタイムズ3d

Takeda picks first female CEO of centuries-old drugmaker

Julie Kim, 54, has been running Takeda’s U.S. operations since 2022 and will assume the role of CEO in June next year, ...

2don MSN

Drugmaker Takeda's CEO Weber to step down, raises profit forecast

Takeda Pharmaceutical said on Thursday its CEO Christophe Weber will retire after more than a decade at the helm of Japan's ...

Takeda picks first woman as CEO of centuries-old drugmaker

Julie Kim has been running Takeda’s US operations since 2022 and will assume the role of CEO in June next year, subject to shareholder approval.

FiercePharma2d

Fierce Pharma Asia—Takeda's next CEO; Enhertu's novel FDA nod; East Asian American C-suite execs

Takeda is promoting U.S. chief Julie Kim to be its next CEO. AstraZeneca and Daiichi's Enhertu has won an FDA nod to expand into HER2-ultralow breast cancer. | Takeda is promoting U.S. chief Julie Kim ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results